A detailed history of Quartz Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Quartz Partners, LLC holds 25,082 shares of NVS stock, worth $3.32 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares
25,082
Previous 25,219 0.54%
Holding current value
$3.32 Million
Previous $2.81 Billion 7.96%
% of portfolio
1.39%
Previous 1.71%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$101.96 - $121.01 $13,968 - $16,578
-137 Reduced 0.54%
25,082 $3.04 Billion
Q1 2025

May 14, 2025

BUY
$97.14 - $115.57 $685,419 - $815,461
7,056 Added 38.85%
25,219 $2.81 Billion
Q4 2024

Feb 04, 2025

BUY
$96.78 - $117.18 $82,553 - $99,954
853 Added 4.93%
18,163 $1.77 Billion
Q3 2024

Nov 08, 2024

BUY
$106.13 - $120.89 $1.84 Million - $2.09 Million
17,310 New
17,310 $1.99 Billion

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $285B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Quartz Partners, LLC Portfolio

Follow Quartz Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quartz Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quartz Partners, LLC with notifications on news.